Please use this identifier to cite or link to this item:
Title: miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice
Author: Clapé, Cyrielle
Fritz, Vanessa
Henriquet, Corinne
Apparailly, Florence
Fernández Ruiz, Pedro Luis
Iborra, François
Avancès, Christophe
Villalba, Martin
Culine, Stéphane
Fajas, Lluis
Keywords: Micro RNAs
Càncer de pròstata
Prostate cancer
Issue Date: 26-Oct-2009
Publisher: Public Library of Science (PLoS)
Abstract: Abstract Background: Micro RNAs are small, non-coding, single-stranded RNAs that negatively regulate gene expression at the post-transcriptional level. Since miR-143 was found to be down-regulated in prostate cancer cells, we wanted to analyze its expression in human prostate cancer, and test the ability of miR-43 to arrest prostate cancer cell growth in vitro and in vivo. Results: Expression of miR-143 was analyzed in human prostate cancers by quantitative PCR, and by in situ hybridization. miR-143 was introduced in cancer cells in vivo by electroporation. Bioinformatics analysis and luciferase-based assays were used to determine miR-143 targets. We show in this study that miR-143 levels are inversely correlated with advanced stages of prostate cancer. Rescue of miR-143 expression in cancer cells results in the arrest of cell proliferation and the abrogation of tumor growth in mice. Furthermore, we show that the effects of miR-143 are mediated, at least in part by the inhibition of extracellular signal-regulated kinase-5 (ERK5) activity. We show here that ERK5 is a miR-143 target in prostate cancer. Conclusions: miR-143 is as a new target for prostate cancer treatment.
Note: Reproducció del document publicat a:
It is part of: PLoS One, 2009, vol. 4, num. 10, p. e7542
Related resource:
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)

Files in This Item:
File Description SizeFormat 
586952.pdf908.88 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons